RADX vs AAUS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RADX Captures Institutional Edge (1โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Radiopharm Theranostics Limited American Depositary Shares (RADX) driven by superior Growth & Margin while AAUS counters with relative strength in Momentum & Technical. Fundamentally, RADX trades at N/M Forward P/E with -411.6% operating margin (-36.9% YoY revenue) versus AAUS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RADX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AAUS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RADX | AAUS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $10.6M | N/A | Larger Scale | RADX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -36.9% | N/A | Higher Growth | RADX |
| Operating Margin (TTM) Profitability | -411.6% | N/A | Higher Margin | RADX |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | RADX |
| Return on Equity (ROE) Capital Efficiency | -174.7% | N/A | Higher ROE | RADX |
| 52-Week Range Position Momentum | 0% ($1โ$16) | 32% ($51โ$64) | Stronger Trend | AAUS |
| Beta / 30D Volatility Risk Regime | 0.52ฮฒ ยท 109% Vol | 0.97ฮฒ ยท 24% Vol | Lower Realized Risk | AAUS |
| Unified Institutional Score Composite Signal | 41.1 / 100 (SELL) | 43.4 / 100 (HOLD) | Higher Composite | AAUS |